Assignee
Galderma Holding SA
CH·44 granted patents·31 pending applications·36 citations·filing 2013–2025
Top patents by PatentIndex Score
75 records- 0193US11708461B2Method for preparing acylated crosslinked glycosaminoglycansGalderma Holding SA·Filed 2020·Granted Jul 25, 2023·2 cites·23 claims
- 0293US11643509B2Carbohydrate crosslinkerGalderma Holding SA·Filed 2022·Granted May 9, 2023·1 cites·20 claims
- 0393US11254792B2Method for deacetylation of biopolymersGalderma Holding SA·Filed 2016·Granted Feb 22, 2022·3 cites·13 claims
- 0492US12390597B2Track-indexed syringeGalderma Holding SA·Filed 2024·Granted Aug 19, 2025·1 cites·20 claims
- 0592US2026035519A1Process for efficient cross-linking of hyaluronic acidGalderma Holding SA·Filed 2025·Application pending·0 cites
- 0689US12454602B2Process for efficient cross-linking of hyaluronic acidGalderma Holding SA·Filed 2023·Granted Oct 28, 2025·0 cites·19 claims
- 0789US2024199822A1Method for preparing acylated crosslinked glycosaminoglycansGalderma Holding SA·Filed 2024·Application pending·0 cites
- 0888US11939433B2Method for preparing acylated crosslinked glycosaminoglycansGalderma Holding SA·Filed 2023·Granted Mar 26, 2024·0 cites·20 claims
- 0988US11504479B2Track-indexed syringeGalderma Holding SA·Filed 2020·Granted Nov 22, 2022·2 cites·18 claims
- 1087US2023416469A1Carbohydrate crosslinkerGalderma Holding SA·Filed 2023·Application pending·0 cites
- 1186US11458226B2Method of soft tissue augmentationGalderma Holding SA·Filed 2019·Granted Oct 4, 2022·2 cites·20 claims
- 1285US11780970B2Carbohydrate crosslinkerGalderma Holding SA·Filed 2023·Granted Oct 10, 2023·0 cites·20 claims
- 1385US11224566B2Composition comprising a crosslinked hyaluronic acid (HA) in combination with a low-molecular HA and/or an agent stimulating endogenous HA synthesisGalderma Holding SA·Filed 2019·Granted Jan 18, 2022·3 cites·21 claims
- 1485US2025375576A1Track-indexed syringeGalderma Holding SA·Filed 2025·Application pending·0 cites
- 1582US12365768B2Method for deacetylation of biopolymersGalderma Holding SA·Filed 2022·Granted Jul 22, 2025·0 cites·20 claims
- 1682USD973873SSyringeGalderma Holding SA·Filed 2021·Granted Dec 27, 2022·9 cites·1 claims
- 1781US12540219B2Method for deacetylation of biopolymersGalderma Holding SA·Filed 2021·Granted Feb 3, 2026·0 cites·21 claims
- 1880US2022347198A1Treatment of Inflammatory Lesions of Rosacea with IvermectinGalderma Holding SA·Filed 2022·Application pending·0 cites
- 1979US11896806B2Track-indexed syringeGalderma Holding SA·Filed 2022·Granted Feb 13, 2024·0 cites·17 claims
- 2078USD1025354SSyringe gripGalderma Holding SA·Filed 2021·Granted Apr 30, 2024·8 cites·1 claims
- 2178US2026022214A1Carbohydrate crosslinkerGalderma Holding SA·Filed 2025·Application pending·0 cites
- 2277US12252594B2Method of preparing a hydrogel productGalderma Holding SA·Filed 2019·Granted Mar 18, 2025·0 cites·29 claims
- 2377US11866556B2Process for efficient cross-linking of hyaluronic acidGalderma Holding SA·Filed 2021·Granted Jan 9, 2024·0 cites·21 claims
- 2475US2024058268A1Methods of treating skin disordersGalderma Holding SA·Filed 2023·Application pending·0 cites
- 2575US2025333430A1Process for the production of dath and intermediates thereof0Galderma Holding SA·Filed 2024·Application pending·0 cites
- 2674US2023346680A1High molecular weight esthetic compositionsGalderma Holding SA·Filed 2023·Application pending·0 cites
- 2773US11896737B2Injectable gel productGalderma Holding SA·Filed 2022·Granted Feb 13, 2024·0 cites·35 claims
- 2872US11702484B2Method for manufacturing a shaped cross-linked hyaluronic acid productGalderma Holding SA·Filed 2021·Granted Jul 18, 2023·0 cites·22 claims
- 2972US2022257509A1Methods of treating skin disordersGalderma Holding SA·Filed 2022·Application pending·0 cites
- 3072US2025281377A1Topical hydration compositionsGalderma Holding SA·Filed 2023·Application pending·0 cites
- 3171US2024384043A1Methods of producing crosslinked hyaluronic acid hydrogels with desirable gel propertiesGalderma Holding SA·Filed 2024·Application pending·0 cites
- 3270US2025243326A1Method of preparing a hydrogel productGalderma Holding SA·Filed 2025·Application pending·0 cites
- 3369US2022031714A1Modified release doxycycline compositionGalderma Holding SA·Filed 2021·Application pending·0 cites
- 3468US12202854B2Process for the production of DATH and intermediates thereofGalderma Holding SA·Filed 2022·Granted Jan 21, 2025·0 cites·15 claims
- 3568US11033565B2Topical application of ivermectin for the treatment of dermatological conditions/afflictionsGalderma Holding SA·Filed 2017·Granted Jun 15, 2021·0 cites·36 claims
- 3667USD1116104SSyringe gripGalderma Holding SA·Filed 2025·Granted Mar 3, 2026·0 cites·1 claims
- 3767US11730691B2High molecular weight esthetic compositionsGalderma Holding SA·Filed 2020·Granted Aug 22, 2023·0 cites·12 claims
- 3866US11236157B2Treatment of skin lesions and pruritus in prurigo nodularis patientsGalderma Holding SA·Filed 2020·Granted Feb 1, 2022·1 cites·25 claims
- 3964US10982016B2Method for manufacturing a shaped cross-linked hyaluronic acid productGalderma Holding SA·Filed 2020·Granted Apr 20, 2021·0 cites·25 claims
- 4064US2025032388A1Personal care compositions for sensitive skin and methods of useGalderma Holding SA·Filed 2024·Application pending·0 cites
- 4163US12371513B2Post-crosslinking partial degradation of amide crosslinked hydrogelsGalderma Holding SA·Filed 2021·Granted Jul 29, 2025·0 cites·17 claims
- 4263US11389567B2Injectable gel productGalderma Holding SA·Filed 2020·Granted Jul 19, 2022·0 cites·22 claims
- 4363US11021580B2Process for efficient cross-linking of hyaluronic acidGalderma Holding SA·Filed 2016·Granted Jun 1, 2021·0 cites·13 claims
- 4463US2026055389A1Method of purifying botulinum toxinGalderma Holding SA·Filed 2025·Application pending·0 cites
- 4563US2024091406A1Multi-component hydrogel gel and uses of the sameGalderma Holding SA·Filed 2023·Application pending·0 cites
- 4662US11235087B2Ready-to-use esthetic compositionsGalderma Holding SA·Filed 2020·Granted Feb 1, 2022·0 cites·27 claims
- 4761US2025352464A1Topical compositions and methods for treating dermatoporosisGalderma Holding SA·Filed 2025·Application pending·0 cites
- 4860US12435147B2Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriationGalderma Holding SA·Filed 2020·Granted Oct 7, 2025·0 cites·14 claims
- 4960US2026028458A1High-durability glycosaminoglycan gels and methods of making the sameGalderma Holding SA·Filed 2025·Application pending·0 cites
- 5059US12583868B2JAK inhibitors and methods for synthesizing and using thereofGalderma Holding SA·Filed 2023·Granted Mar 24, 2026·0 cites·12 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Galderma Holding SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →